Search results for: 'pics point analysis for laboratory develop test life'
- Did you mean
- pacs point analysis for laboratory develop test life
- price point analysis for laboratory develop test life
- Related search terms
- Point-of-Care Testing (POCT) Market
- analysis of the north american radiology image and information management systemnorth american radiology pacs and (ris(ris pacs) market
- analysis-of-the-ethiopian-pharmaceutical-market.html
- analysis of the drug delivery devices market forecast to 2023
- Point-of-Care Testing Market, Global, 2024–2031
-
23 Jun 2016  |  North America  |  Market Research
Growth Opportunities in the US Point-of-care Testing Market
Digital Health Meets Point of Care—Emergence of Mobile Molecular Diagnostics
The US point-of-care testing (POCT) study provides an extensive analysis for 13 segments: hematology, urinalysis, infectious disease, cardiac, HbA1c, glucose, fecal occult blood test/fecal immunochemical test (FOBT/FIT), coagulation PT/INR, coagulation APTT/ACT, cholesterol, pregnancy, drugs of abuse, and blood gas and electrolytes. Key trends and ...
$4,950.00 -
23 Jan 2026  |  Global  |  Market Research
Benchmarking of Global Charging Point Operators (CPOs), 2024–2031
Global CPOs Face Consolidation, Rising Demand, Technology Upgrades, and Accelerating Growth through Partnerships and Revenue Diversification
This benchmarking study offers a detailed and structured evaluation of the global charging point operator (CPO) ecosystem, capturing its evolution amid the rapid acceleration of electric mobility worldwide. It highlights strategic initiatives, competitive positioning, and long-term growth priorities shaping the next phase of the charging industry. ...
$4,950.00 -
26 Mar 2010  |  North America  |  Market Research
U.S. Point-of-care Testing Markets
This research service analyzes the market for point-of-care testing within the United States. The market is divided into 13 segments and covers testing performed by healthcare professionals in the physician office lab, hospital, clinics, and patient self-testing environments. Each segment covers the market overview, competitive structure, market s...
$4,950.00 -
23 Aug 2022  |  North America  |  Market Research
Global Bioanalytical Testing Services, 2021–2027
Acquisition of Disruptive Technologies will be the Key to Driving Growth
As the pharma market recovers from the debilitating impact of COVID-19 on the drug discovery and development pipelines, there is an increasing requirement for outsourcing services in the form of contract research organizations (CROs) and contract development & manufacturing organizations (CDMOs), which is likely to drive the already strong drug dev...
$4,950.00 -
22 Aug 2024  |  Global  |  Frost Radar
Frost Radar™: Economic Development, 2024
The United States, Switzerland, and Germany are Global Frontrunners as Sustainability, Manufacturing Competitiveness, and Industry 5.0 Take Center Stage
With persistent geopolitical tensions and the resultant trade fragmentation continuing to shape the global economy, policy priorities among countries advanced and emerging are shifting toward macroeconomic frameworks that will insulate them from external shocks. Incremental reforms that support sustainability and Industry 5.0 practices will have pr...
$4,950.00 -
22 Jun 2026  |  Global  |  Market Research
Growth Opportunities, Global Life Sciences LIMS Market, Forecast to 2031
AI is Transforming Life Sciences LIMS by Automating Analysis, Enabling Predictive Insights, and Improving Efficiency and Decision-making
The global life sciences laboratory information management systems (LIMS) industry is forecast to grow from 2026 to 2031 at a CAGR of 8.5%, driven by the increasing need for laboratory automation, regulatory compliance, and cloud-based solutions. Leading players in the global life sciences LIMS market, including LabWare, Benchling, Clinisys, LabVan...
$4,950.00 -
20 Mar 2019  |  North America  |  Market Research
Growth Opportunities in the North American Clinical Laboratory Services Market, Forecast to 2022
Laboratories Seek Alternate Revenue Streams to Combat Reimbursement Pressure
Clinical laboratory services represent one of the highest healthcare expenditures in North America, yet the United States and Canada represent different scenarios in the way clinical services are rendered. The market for clinical lab services in Canada was an estimated $10.33 billion in 2017 whereas in the United States it was an estimated $78.33 b...
$4,950.00 -
11 Feb 2019  |  North America  |  Market Research
Global Laboratory Products Purchasing Trends, 2018–2019
An End-user Perspective on Laboratory Spending Reveals Modest 2019 Budget Increases Following Healthier 2018 Spending
Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey in September 2018 that centered around the state of their laboratories in 2018 and their expectations for 2019. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. Where applicable, the study presents year-o...
$1,500.00 -
16 Nov 2023  |  Global  |  Market Research
Growth Opportunities in Semiconductor Automated Test Equipment
Increasing Application Content Driven by Digitization, Electrification, AI, and Sustainability to Catalyze Demand for ATE in Both Leading edge and Mature Process Nodes
Most production organizations once viewed test systems as non-productive assets. If not for the need for quality, verification, and validation, test system manufacturers may not have been as successful as they are. The semiconductor ATE market emerged because of the increasing need for safe and reliable products that comply with regulations and sta...
$4,950.00 -
12 Feb 2024  |  Global  |  Market Research
Innovation Waves in Immuno-oncology Therapy Development
Next-gen Cell Therapies and Precision Immunotherapies are Driving Growth and New Product Development
Immuno-oncology (I-O) therapies target tumors by harnessing the host s immune system. With the growing incidence and prevalence of various types of aggressive and refractory cancers, the next-generation I-O therapy pipeline has witnessed significant growth. Chimeric antigen receptor (CAR)-T cell therapy and tumor-targeted antibody therapies, includ...
$4,950.00